Patent Yard Sign in
Canadian application, no grantCanada

Novel cyclic tetrapeptide derivatives and pharmaceutical use thereof

CA 2362817 A1 · Owner: Horinouchi, Sueharu · Inventors: Komatsu, Yasuhiko; Yoshida, Minoru; Nishino, Norikazu

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Cyclic tetrapeptide derivatives represented by general formula (I) or pharmaceutically acceptable salts thereof: (wherein R21 and R22 are each independently hydrogen, linear C1-C6 alkyl to which a nonaromatic cycloalkyl group or an optionally substituted aromatic ring may be bonded or branched C3-, C6 alkyl to which a nonaromatic cycloalkyl group or an optionally substituted aromatic ring may be bonded; and R1 and R3 are each independently linear C1-C5 alkylene which may have a C1-C6 side chain and the side chain may form a , fused ring structure on the alkylene chain). Histone deacetylase inhibitors MHC class I molecule development promotors and drug compositions containing , as the …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 28, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 28, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 28, 2000
GrantedNo grant recorded
Term endedFebruary 28, 2020
Patent numberCA 2362817 A1
Classification (IPC)C07K5/12 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedFeb 28, 2000Term endedFeb 28, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.